INTERVENTIONS FOR IMPROVING OUTCOMES OF CHILDREN WHO ARE DEAF OR HARD OF HEARING
Professor Teresa Y C Ching
Professorial Fellow, NextSense Institute, Sydney;
Conjoint Professor, Macquarie University, Sydney;
Honorary Professor, University of Queensland, Brisbane, Australia
RESEARCHER PROFILE
Filmed in Sydney | June 2025
About two to six per thousand children have a hearing loss that prevents them from achieving their full potential in life. They experience many more difficulties in cognitive, language and social development than their hearing peers. We know that early detection through newborn hearing screening is crucial, but less is known about how intervention can best be targeted to meet the needs of individual children and their families.
Professor Teresa Ching has led population-based studies that drive evidence-based practice in intervention for improving outcomes of children who are deaf or hard of hearing. Much of her research findings have been translated into practice and policy. However, many children from culturally and linguistically diverse backgrounds remain vulnerable, requiring intervention tailored to their needs. Furthermore, many children have undetected, untreated hearing problems when they enter school, thereby reducing their educational attainment and social participation.
Teresa is a Conjoint Professor at NextSense Institute and Macquarie University, and an Honorary Professor at the University of Queensland in Australia. Her current research focuses on devising culturally sensitive practices in early detection and intervention to maximise children’s outcomes. Working with international colleagues, her current research is also directed towards developing global guidelines and recommendations for hearing screening beyond the newborn period, so that all children can benefit from early detection and intervention. The ultimate goal is to attain equity of care and outcomes for all children with hearing difficulties.
Source: Supplied
-
ROCK-induced early-onset bowel cancer progression
Professor Michael Samuel is a cell biologist whose research interest is in understanding how cancer mechanobiology influences the tumour microenvironment, thereby promoting tumour progression. He is Professor of Matrix Biology at the University of South Australia, Adelaide and heads the Tumour Microenvironment Laboratory at the Centre for Cancer Biology and the Cancer Mechanotherapies Laboratory at the Basil Hetzel Institute for Translational Health Research.
-
Next-generation NK cell-based immunotherapies for hard-to-treat cancers
Associate Professor Fernando Guimaraes is an internationally recognised leader in cancer immunotherapy and natural killer (NK) cell biology. Based at The University of Queensland, he leads innovative research focused on developing next-generation NK cell-based immunotherapies for hard-to-treat cancers, including sarcomas and neuroblastoma.
-
Nutraceutical and pharmacological intervention in neurological disorders
Dr Virginie Lam is a neuroscientist and cerebrovascular biologist with over 15 years of research experience, including more than seven years post-PhD. She co-leads the Neurovascular and Metabolic Diseases Laboratory at the Curtin Medical Research Institute and holds an affiliate appointment at the Perron Institute for Neurological and Translational Science. Her research focuses on the interface between neurovascular health, cognitive function, and therapeutic translation in neurodegenerative disorders.
